Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids
Roberta Venè1, Patrizia Larghero, Giuseppe Arena
1Molecular Oncology and Angiogenesis Laboratory, Istituto Nazionale per la Ricerca sul Cancro (IST), Genova, Italy.
Abstract:
The induction of programmed cell death in premalignant or malignant cancer cells by chemopreventive agents could be a valuable tool to control prostate cancer initiation and progression. In this work, we present evidence that the C-28 methyl ester of the synthetic oleanane triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO-Me) induces cell death in androgen-responsive and unresponsive human prostate cancer cell lines at nanomolar and low micromolar concentrations. CDDO-Me induced caspase-3, caspase-8, and caspase-9 activation; poly(ADP-ribose) polymerase cleavage; internucleosomal DNA fragmentation; and loss of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction in PC3 and DU145 cells. However, caspase-3 and caspase-8 inhibition by Z-DEVD-fmk and Z-IETD-fmk, respectively, or general caspase inhibition by BOC-D-fmk or Z-VAD-fmk did not rescue loss of cell viability induced by CDDO-Me, suggesting the activation of additional caspase-independent mechanisms. Interestingly, CDDO-Me induced inactivating phosphorylation at Ser(9) of glycogen synthase kinase 3beta (GSK3beta), a multifunctional kinase that mediates essential events promoting prostate cancer development and acquisition of androgen independence. The GSK3 inhibitor lithium chloride and, more effectively, GSK3 gene silencing sensitized PC3 and DU145 prostate cancer cells to CDDO-Me cytotoxicity. These data suggest that modulation of GSK3beta activation is involved in the cell death pathway engaged by CDDO-Me in prostate cancer cells.
Insights
The synthetic triterpenoid CDDO-Me induces programmed cell death in prostate cancer cells. This compound activates caspase-independent pathways and modulates glycogen synthase kinase 3beta (GSK3beta) activity, suggesting a novel therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Programmed cell death induction is a key strategy for controlling prostate cancer.
- Synthetic oleanane triterpenoids, like CDDO-Me, show potential as chemopreventive agents.
Purpose of the Study:
- To investigate the mechanism of cell death induced by CDDO-Me in human prostate cancer cells.
- To explore the role of glycogen synthase kinase 3beta (GSK3beta) in CDDO-Me-mediated cytotoxicity.
Main Methods:
- Treatment of androgen-responsive and unresponsive prostate cancer cell lines (PC3, DU145) with CDDO-Me.
- Assays for caspase activation, poly(ADP-ribose) polymerase cleavage, DNA fragmentation, and cell viability.
- Inhibition of caspases and GSK3beta (using inhibitors or gene silencing) to assess their role in CDDO-Me cytotoxicity.
Main Results:
- CDDO-Me induced apoptosis markers (caspase activation, DNA fragmentation) and reduced cell viability in prostate cancer cells.
- Caspase inhibition did not fully rescue cell death, indicating caspase-independent mechanisms.
- CDDO-Me induced inactivating phosphorylation of GSK3beta, and GSK3 inhibition sensitized cells to CDDO-Me.
Conclusions:
- CDDO-Me effectively induces cell death in prostate cancer cells through both caspase-dependent and -independent pathways.
- Modulation of GSK3beta activity is implicated in the cytotoxic effects of CDDO-Me.
- CDDO-Me represents a promising therapeutic agent for prostate cancer, potentially by targeting GSK3beta.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
TGF - β Signaling Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Amplifying Signals via Enzymatic Cascade
The Intrinsic Apoptotic Pathway

